| http://www.w3.org/ns/prov#value | - eptor of human NKT cells in an activating ability of human natural killer T (NKT) cells and is used ina formulation where the activation can be sustained. [0013] Another embodiment of the present invention is a composition mainly comprising a saccharide having an ??1???3 steric structure which selectively acts on NKR-P1 which is a natural killer (NK) cell antigen receptor of human NKT cells whereb
|
